Combination therapy improves outcomes for relapsed chronic lymphocytic leukemia

By | August 6, 2021
Shuo Ma, MD, ’00 PhD, associate professor of Medicine in the Division of Hematology and Oncology, was co-first author of the clinical trial published in Blood.